-
Woodcock to step up to interim FDA chief as she and Sharfstein are vetted for permanent job: reportsFDA veteran Janet Woodcock will take over as commissioner, at least temporarily, according to media reports, and former deputy FDA chief Joshua Sharfstein is at the top of the list for the permanent2021/1/15
-
Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain vaccinePfizer’s $5.8 billion-a-year Prevnar 13 is one of the company’s top blockbusters and the undisputed leader in the market for pneumococcal vaccines. But when it comes to the next generation of pneumon2021/1/13
-
JPM: Alexion gives an updated look at what AstraZeneca's getting for $39BToward the end of 2020, AstraZeneca splashed out $39 billion for Alexion to expand its immunology presence. That's a big price—and questions naturally followed about whether it was justified. Now, th2021/1/13
-
Look out, pharma. A 'tidal wave' of side effect reports is coming amid COVID-19 vaccine rolloutsWith COVID-19 vaccine launches gaining steam—and an unprecedented level of media coverage zeroed in—pharma companies of all stripes should brace not only for a wave of adverse event reports, experts2021/1/11
-
Should pharma charity contributions be publicly disclosed, just like doctor payments? Senators say yesPharma companies have inked a series of federal settlements over payments to charity organizations, which the federal government argues are a “conduit” to boosting drug sales. Now, after an opioid in2021/1/11
-
Catalent inks deal to offload blow-fill-seal business to SK CapitalNew Jersey CDMO Catalent made waves last year as it inked one COVID-19 vaccine manufacturing deal after another, all the while continuing its push into cell and gene therapy. Now, the manufacturer is2021/1/8
-
Fujifilm socks $2B into new U.S. site as its global CDMO ambitions take shapeSeeking todramatically bolster its position in the contract development and manufacturing business, Fujifilm isinvesting$2 billion on a large cell culture production site in the U.S. The site will fe2021/1/8
-
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikesPharma's routine January price hikes are here once again—and not even a global pandemic seems to be slowing thenumberof increases. Amid ongoingscrutiny from politicians and the public, though, the2021/1/5
-
Judge blocks Trump's 'most favored nation' drug pricing ruleWelcome to theFiercePharmapolitical roundup, where each Monday we’ll highlight developments that could affect drug pricing and howdrugmakersoperate. While the holiday season often brings a lul2021/1/5
-
Pfizer, feds ink another COVID-19 vaccine supply deal for 100M dosesAfter an initial coronavirus vaccine supply deal inked this summer and a tense back-and-forth last week between the federal government and Pfizer, the two sides have forged another supply agreement.2020/12/31